VAI & Wageningen University and Research’s scientists used a CRISPR variant to distinguish tumor DNA from healthy DNA by targeting chemical differences present in cancer cells. Published in @nature.com, the study is a promising step toward cancer therapy that targets tumor cells with high precision.
